Tafluprost (Saflutan®)

Assessment Status Rapid Review Complete
HTA ID -
Drug Tafluprost
Brand Saflutan®
Indication For the reduction of elevated intraocular pressure in open angle glaucoma and ocular hypertension.
Assessment Process
Rapid review commissioned 25/03/2011
Rapid review completed 09/04/2011
Rapid review outcome Full Pharmacoeconomic Assessment Not Recommended.